Ocular Therapeutix (OCUL) Gross Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 526.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -5.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -165.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 21,616.00
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn 11,993.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11,993.00
Dec 31, 2025 -9,059.00
Sep 30, 2025 5,635.00
Jun 30, 2025 -527.00
Mar 31, 2025 -12,327.00
Dec 31, 2024 24,044.00
Sep 30, 2024 -678.00
Jun 30, 2024 6,426.00
Mar 31, 2024 10.00
Dec 31, 2023 -24,046.00
Sep 30, 2023 2,337.00
Jun 30, 2023 -6,403.00
Mar 31, 2023 5,965.00
Dec 31, 2022 181.00
Sep 30, 2022 -7,435.00
Jun 30, 2022 6,219.00
Mar 31, 2022 4,141.00
Dec 31, 2021 -25,012.00
Sep 30, 2021 10,018.00
Jun 30, 2021 32,055.00
Mar 31, 2021 16,315.00
Dec 31, 2020 -42,484.00
Sep 30, 2020 70,653.00
Jun 30, 2020 71,938.00
Mar 31, 2020 40,700.00
Dec 31, 2019 68,917.00
Sep 30, 2019 -79,440.00
Jun 30, 2019 -97,774.00
Mar 31, 2019 -46,940.00
Dec 31, 2018 16,221.00
Sep 30, 2018 59,603.00
Jun 30, 2018 142,602.00
Mar 31, 2018 105,796.00
Dec 31, 2017 106,409.00
Sep 30, 2017 -59,564.00
Jun 30, 2017 -153,601.00
Mar 31, 2017 -124,504.00
Dec 31, 2016 -32,946.00
Sep 30, 2016 19,847.00
Jun 30, 2016 20,299.00
Mar 31, 2016 -27.00
Dec 31, 2015 -53,965.00
Sep 30, 2015 -19,957.00
Jun 30, 2015 -20,618.00
Mar 31, 2015 112,462.00